Breakthrough in malaria research looks to body's immune cells

Groundbreaking research from the Queensland Institute of Medical Research is set to pave the way for the development of new malaria drugs and vaccines.

Dr Michelle Wykes and her team from QIMR have recently published new findings demonstrating how the can survive in a type of white blood cell in the .

Traditionally, it was believed the parasite’s development in the body was restricted to the liver and red blood cells.

Dr Wykes’ research, undertaken over several years, provides a major breakthrough in our understanding of the malaria parasites.

Dr Wykes said the findings open up a whole new approach to developing drugs and vaccines targeting the infection in the spleen.

“Our research has discovered how called dendritic cells, malfunction and shield the malaria parasite from the body’s immune attack.

“Dendritic cells normally function like generals of an army, giving orders to the body’s immune cells to fight infection,” Dr Wykes said.

“The system usually works brilliantly. However, the problem with malaria is that the disease has found a way to block dendritic cells from doing their work, meaning that the disease over-rides our immune responses. And therefore, people get sick.”

Dr Wykes was awarded a $300,000 Queensland Government Smart State fellowship in 2010 to assist her research.

“The fellowship has enabled me to progress my research and without it I wouldn’t have been able to deliver these new findings which are a major step in fighting the global problem of malaria,” Dr Wykes said.

The findings were published in the prestigious scientific journal Proceedings of the National Academy of Sciences of the United States of America.

Malaria affects more than 200 million people worldwide, causing nearly 800,000 deaths per year, mostly young children under five.

The World Health Organisation states most deaths occur in Africa where a child dies of every 45 seconds and the disease accounts for approximately 20 percent of all childhood deaths.

Provided by Queensland Institute of Medical Research

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Blood-thinning copycat enters malaria fight

Jun 01, 2010

New treatments for malaria are possible after Walter and Eliza Hall Institute scientists found that molecules similar to the blood-thinning drug heparin can stop malaria from infecting red blood cells.

Recommended for you

Testing time for stem cells

1 hour ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

20 hours ago

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments